Click for best price
Peptides Biosimilars Market Size, Share 2023
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. The statistic scope in this report is peptides biosimilars.
This report aims to provide a comprehensive presentation of the global market for Peptides Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptides Biosimilars. This report contains market size and forecasts of Peptides Biosimilars in global, including the following market information:
Global Peptides Biosimilars Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Peptides Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Glucagon Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peptides Biosimilars include Sandoz, Pfizer, Teva Pahrmaceutical, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan and Dr. Reddy's Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptides Biosimilars companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptides Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Peptides Biosimilars Market Segment Percentages, by Type, 2022 (%)
Glucagon
Calcitonin
Global Peptides Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Peptides Biosimilars Market Segment Percentages, by Application, 2022 (%)
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Global Peptides Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Peptides Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptides Biosimilars revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptides Biosimilars revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptides Biosimilars, market overview.
Chapter 2: Global Peptides Biosimilars market size in revenue.
Chapter 3: Detailed analysis of Peptides Biosimilars company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptides Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Peptides Biosimilars Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptides Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptides Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptides Biosimilars Overall Market Size
2.1 Global Peptides Biosimilars Market Size: 2022 VS 2029
2.2 Global Peptides Biosimilars Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptides Biosimilars Players in Global Market
3.2 Top Global Peptides Biosimilars Companies Ranked by Revenue
3.3 Global Peptides Biosimilars Revenue by Companies
3.4 Top 3 and Top 5 Peptides Biosimilars Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peptides Biosimilars Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptides Biosimilars Players in Global Market
3.6.1 List of Global Tier 1 Peptides Biosimilars Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptides Biosimilars Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptides Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Glucagon
4.1.3 Calcitonin
4.2 By Type - Global Peptides Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Peptides Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Peptides Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Peptides Biosimilars Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptides Biosimilars Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Chronic Diseases
5.1.4 Autoimmune Diseases
5.1.5 Blood Disorders
5.1.6 Growth Hormone Deficiency
5.1.7 Infectious Diseases
5.1.8 Other Diseases
5.2 By Application - Global Peptides Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Peptides Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Peptides Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Peptides Biosimilars Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Peptides Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Peptides Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Peptides Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Peptides Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Peptides Biosimilars Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Peptides Biosimilars Revenue, 2018-2029
6.3.2 US Peptides Biosimilars Market Size, 2018-2029
6.3.3 Canada Peptides Biosimilars Market Size, 2018-2029
6.3.4 Mexico Peptides Biosimilars Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Peptides Biosimilars Revenue, 2018-2029
6.4.2 Germany Peptides Biosimilars Market Size, 2018-2029
6.4.3 France Peptides Biosimilars Market Size, 2018-2029
6.4.4 U.K. Peptides Biosimilars Market Size, 2018-2029
6.4.5 Italy Peptides Biosimilars Market Size, 2018-2029
6.4.6 Russia Peptides Biosimilars Market Size, 2018-2029
6.4.7 Nordic Countries Peptides Biosimilars Market Size, 2018-2029
6.4.8 Benelux Peptides Biosimilars Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Peptides Biosimilars Revenue, 2018-2029
6.5.2 China Peptides Biosimilars Market Size, 2018-2029
6.5.3 Japan Peptides Biosimilars Market Size, 2018-2029
6.5.4 South Korea Peptides Biosimilars Market Size, 2018-2029
6.5.5 Southeast Asia Peptides Biosimilars Market Size, 2018-2029
6.5.6 India Peptides Biosimilars Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Peptides Biosimilars Revenue, 2018-2029
6.6.2 Brazil Peptides Biosimilars Market Size, 2018-2029
6.6.3 Argentina Peptides Biosimilars Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptides Biosimilars Revenue, 2018-2029
6.7.2 Turkey Peptides Biosimilars Market Size, 2018-2029
6.7.3 Israel Peptides Biosimilars Market Size, 2018-2029
6.7.4 Saudi Arabia Peptides Biosimilars Market Size, 2018-2029
6.7.5 UAE Peptides Biosimilars Market Size, 2018-2029
7 Peptides Biosimilars Companies Profiles
7.1 Sandoz
7.1.1 Sandoz Company Summary
7.1.2 Sandoz Business Overview
7.1.3 Sandoz Peptides Biosimilars Major Product Offerings
7.1.4 Sandoz Peptides Biosimilars Revenue in Global Market (2018-2023)
7.1.5 Sandoz Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Peptides Biosimilars Major Product Offerings
7.2.4 Pfizer Peptides Biosimilars Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Teva Pahrmaceutical
7.3.1 Teva Pahrmaceutical Company Summary
7.3.2 Teva Pahrmaceutical Business Overview
7.3.3 Teva Pahrmaceutical Peptides Biosimilars Major Product Offerings
7.3.4 Teva Pahrmaceutical Peptides Biosimilars Revenue in Global Market (2018-2023)
7.3.5 Teva Pahrmaceutical Key News & Latest Developments
7.4 Celltrion
7.4.1 Celltrion Company Summary
7.4.2 Celltrion Business Overview
7.4.3 Celltrion Peptides Biosimilars Major Product Offerings
7.4.4 Celltrion Peptides Biosimilars Revenue in Global Market (2018-2023)
7.4.5 Celltrion Key News & Latest Developments
7.5 Biocon
7.5.1 Biocon Company Summary
7.5.2 Biocon Business Overview
7.5.3 Biocon Peptides Biosimilars Major Product Offerings
7.5.4 Biocon Peptides Biosimilars Revenue in Global Market (2018-2023)
7.5.5 Biocon Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Peptides Biosimilars Major Product Offerings
7.6.4 Amgen Peptides Biosimilars Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Samsung Biologics
7.7.1 Samsung Biologics Company Summary
7.7.2 Samsung Biologics Business Overview
7.7.3 Samsung Biologics Peptides Biosimilars Major Product Offerings
7.7.4 Samsung Biologics Peptides Biosimilars Revenue in Global Market (2018-2023)
7.7.5 Samsung Biologics Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Peptides Biosimilars Major Product Offerings
7.8.4 Mylan Peptides Biosimilars Revenue in Global Market (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Company Summary
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Peptides Biosimilars Major Product Offerings
7.9.4 Dr. Reddy's Laboratories Peptides Biosimilars Revenue in Global Market (2018-2023)
7.9.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.10 Stada Arzneimittel AG
7.10.1 Stada Arzneimittel AG Company Summary
7.10.2 Stada Arzneimittel AG Business Overview
7.10.3 Stada Arzneimittel AG Peptides Biosimilars Major Product Offerings
7.10.4 Stada Arzneimittel AG Peptides Biosimilars Revenue in Global Market (2018-2023)
7.10.5 Stada Arzneimittel AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peptides Biosimilars Market Opportunities & Trends in Global Market
Table 2. Peptides Biosimilars Market Drivers in Global Market
Table 3. Peptides Biosimilars Market Restraints in Global Market
Table 4. Key Players of Peptides Biosimilars in Global Market
Table 5. Top Peptides Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Peptides Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Peptides Biosimilars Revenue Share by Companies, 2018-2023
Table 8. Global Companies Peptides Biosimilars Product Type
Table 9. List of Global Tier 1 Peptides Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptides Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peptides Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Peptides Biosimilars Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Peptides Biosimilars Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Peptides Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Peptides Biosimilars Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Peptides Biosimilars Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Peptides Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Peptides Biosimilars Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Peptides Biosimilars Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Peptides Biosimilars Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Peptides Biosimilars Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Peptides Biosimilars Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Peptides Biosimilars Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Peptides Biosimilars Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Peptides Biosimilars Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Peptides Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Peptides Biosimilars Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Peptides Biosimilars Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Peptides Biosimilars Revenue, (US$, Mn), 2024-2029
Table 30. Sandoz Company Summary
Table 31. Sandoz Peptides Biosimilars Product Offerings
Table 32. Sandoz Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 33. Sandoz Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Peptides Biosimilars Product Offerings
Table 36. Pfizer Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Teva Pahrmaceutical Company Summary
Table 39. Teva Pahrmaceutical Peptides Biosimilars Product Offerings
Table 40. Teva Pahrmaceutical Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pahrmaceutical Key News & Latest Developments
Table 42. Celltrion Company Summary
Table 43. Celltrion Peptides Biosimilars Product Offerings
Table 44. Celltrion Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 45. Celltrion Key News & Latest Developments
Table 46. Biocon Company Summary
Table 47. Biocon Peptides Biosimilars Product Offerings
Table 48. Biocon Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 49. Biocon Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Peptides Biosimilars Product Offerings
Table 52. Amgen Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Samsung Biologics Company Summary
Table 55. Samsung Biologics Peptides Biosimilars Product Offerings
Table 56. Samsung Biologics Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 57. Samsung Biologics Key News & Latest Developments
Table 58. Mylan Company Summary
Table 59. Mylan Peptides Biosimilars Product Offerings
Table 60. Mylan Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 61. Mylan Key News & Latest Developments
Table 62. Dr. Reddy's Laboratories Company Summary
Table 63. Dr. Reddy's Laboratories Peptides Biosimilars Product Offerings
Table 64. Dr. Reddy's Laboratories Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 65. Dr. Reddy's Laboratories Key News & Latest Developments
Table 66. Stada Arzneimittel AG Company Summary
Table 67. Stada Arzneimittel AG Peptides Biosimilars Product Offerings
Table 68. Stada Arzneimittel AG Peptides Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 69. Stada Arzneimittel AG Key News & Latest Developments
List of Figures
Figure 1. Peptides Biosimilars Segment by Type in 2022
Figure 2. Peptides Biosimilars Segment by Application in 2022
Figure 3. Global Peptides Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peptides Biosimilars Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Peptides Biosimilars Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptides Biosimilars Revenue in 2022
Figure 8. By Type - Global Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 9. By Application - Global Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 10. By Type - Global Peptides Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 12. By Application - Global Peptides Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 14. By Region - Global Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 15. By Country - North America Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 16. US Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 20. Germany Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 21. France Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 28. China Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 32. India Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 34. Brazil Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Peptides Biosimilars Revenue Market Share, 2018-2029
Figure 37. Turkey Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Peptides Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 41. Sandoz Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pahrmaceutical Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Celltrion Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biocon Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Samsung Biologics Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mylan Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Dr. Reddy's Laboratories Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Stada Arzneimittel AG Peptides Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
